ASSOCIATION OF MTHFR (C677T) AND ACE (I/D) POLYMOR-PHISMS WITH HYPERTENSION AND RESPONSE TO TREAT-MENT AMONG EGYPTIAN PATIENTS
Abstract
Hypertension, a well-known epidemic health disease, is risk factor for various cardiovascular, peripheral vascular and renal diseases. Renin angiotensin system (RAS) being the most important pathogenic mechanism of hypertension is mediated by a key component; the angiotensin converting enzyme (ACE). Moreover, Mutations in the methylenetetrahydrofolate reductase gene (MTHFR) have been established to be associated with the risk of cardiovascular disease as well as hypertension. This case-control study was conducted out to investigate the potential relationship of ACE (I/D) and MTHFR (C677T) gene polymorphisms with hypertension susceptibility and the responsive ability of antihypertensive drugs in Egyptian hypertensive patients. Thirty six patients suffering of high blood pressure were compared with age and sex matching 14 control cases. MTHFR (C677T) and ACE (I/D) polymorphisms were genotyped by polymerase chain reaction (PCR). The demographic and clinical features of patients and control showed no particular significance (p > 0.05) except for the consanguinity and the obesity. For MTHFR polymorphism frequency, total hypertensive cases showed significantly higher frequency rate for the mutant allele 677T compared to controls with a lower frequency of the wild type 677CC genotype. Whereas the mutant 677TC+TT genotypes were not significantly associated with the hypertension risk when compared to the wild genotype among the case group. For ACE gene polymorphism, also showed only higher frequency rates of DD allele. Interestingly, ACE DD genotype showed significant association with blood pressure, obesity and diabetes. Finally in response of the antihypertensive drugs, we found that, the best responsive group is DD genotype group when treated with the ACE inhibitors. These result suggested that the MTHFR polymorphism was not associated with hypertension while the ACE DD genotype may be associated with essential hypertension and considered as a potent risk factor for hypertension and moreover it is the best responsive group when treated with ACE inhibitors in Egyptian patients.References
Agarwal, A., G. H. Williams et al. (2005). Genetics of human hypertension. Trends Endocrinol. Metab., 16: 127-133.
Alaatin, Y. (2000). No association between deletion type ACE gene polymorphism and left ventricular hypertrophy in hemodialysis patients. Nephron., 84: 130-135.
Bayramoglu, A., Urhan Kucuk M. et al. (2015). Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension? Cytotechnol., 67: 115-122.
Cevik, B. I., S. Yigit et al. (2014). Association of methylenetetrahydro-folate reductase gene C677T polymorphism with multiple sclerosis in Turkish patients. J. Investig. Med., 62: 980-984.
Chiang, F. T., T. H. Chern et al. (1996). Age and gender dependent association of ACE gene with essential hypertension in a Chinese population. J. Hum. Hypertens., 10: 823-826.
Chobanian, A. V., G. L. Bakris et al. (2003). The 7th report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. J. Am. Med. Associ., 289: 2560-2572.
Danser, A. H., W. W. Batenburg et al. (2007). ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? Pharmacol. Ther., 113: 607-618.
Dazida, G., J. Sobatyl et al. (2001). Polymorphism of ACE and Ang II receptor type I gene in essential hypertension in Polish population. Clin. Res., 7: 1236-1241.
Duru, K., S. Farrow et al. (1994). Frequency of deletion polymorphism in the gene for ACE is increased in African Americans with hypertension. Am. J. Hypertens., 7: 759-762.
Fontana, V., M. R. Luizon et al. (2015). An update on the pharmacogenetics of treating hypertension. J. Hum. Hypertens., 29: 283-291.
Guilland, J. C., A. Favier et al. (2003). Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? Epi-demiological data. Pathol. Biol., (Paris) 51: 111-121.
Heux, S., F. Morin et al. (2004). The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens. Res., 27: 663-667.
Ilhan, N., M. Kucuksu et al. (2008). The 677C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch. Med. Res., 39: 125-130.
Javed, Y., Marta V. Fowdar et al. (2012). Investigation of Homocysteine-Pathway-Related Variants in Essential Hypertension. Int. J. Hypertens., 190923.
Ji, L. D., L. N. Zhang et al. (2010). Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a metaanalysis. J. Hypertens., 28: 419-428.
Kang, S. S., J. Zhou et al. (1988). Inter-mediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet., 43: 414-421.
Kosmas, I. P., A. Tatsioni et al. (2004). Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J. Hypertens., 22: 1655-1662.
Levy, D., G. B. Ehret et al. (2009). Genome-wide association study of blood pressure and hypertension. Nat. Genet., 41: 677-687.
Maguchi, M. (1996). ACE polymorphism in essential hypertensive patients in Japanese population. Angiolog., 47: 643-648.
Manunta, P. (2002). Are the new single nucleotide polymorphisms relevant for hypertensive populations? J Hypertens., 20: 2335-2346.
Markan, S., M. Sachdeva et al. (2007). MTHFR 677CT/MTHFR 1298CC genotypes are associated with increased risk of hypertension in Indians. Mol. Cell Biochem., 302: 125-131.
Moat, S. J., S. N. Doshi et al. (2001). Folate, homocysteine, endothelial function and cardiovascular disease. What is the link? Biomed. Pharmacother, 55: 425-433.
Morise, T., Y. Takeguchi et al. (1994). ACE polymorphism and essential hypertension. Lancet., 343: 125.
Morshed, M., H. Khan and S. Akhteruzzaman (2002). Association between ACE polymorphism and hypertension in selected individuals of Bangladeshi populations. J. Biochem. Mol. Biol., 35: 251-254.
Nakayama, T., M. Soma et al. (2003). Haplotype analysis of the prostacyclin synthase gene and essential hypertension. Hypertens. Res., 26: 553-557.
Nakno, Y., T. Oshima et al. (1998). Genotype of ACE is a risk factor for early onset of essential hypertension Japanese population. J. Lab. Clin. Med., 13: 502-506.
Newton-Cheh, Ch. et al. (2009). Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet., 41: 666-676.
Shaughnessy, K. M. (2001). The genetics of essential hypertension. Br. J. Clin. Pharmacol., 51: 5-11.
Pamies, A. E., P. C. Palmero et al. (1999). Effect of angiotensinogen M235T and the ACE I/D polymorphism on arterial hypertension and cardio-vascular risk factors. Med. Clin., 113: 164-168.
Qian, X., Z. Lu et al. (2007). A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur. J. Hum. Genet., 15: 1239-1245.
Rigat, B., C. Hubert et al. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86: 1343-1346.
Risch, N. and K. Merikangas (1996). The future of genetic studies of complex human diseases. Science, 273: 1516-1517.
Salem, A. H. and M. A. Batzer (2009). High frequency of the D allele of the angiotensin-converting enzyme gene in Arabic populations. BMC Res. Notes, 2: 99.
Slager, S. L. and D. J. Schaid (2001). Evaluation of candidate genes in case –control studies: a statistical method to account for related subjects. Am. J. Hum. Genet., 68: 1457-1462.
Thiol, B. and A. B. Weber (2002). Genes for essential hypertension. Hype, help or hope? J. Clin. Hypertens., (Greenwich) 2: 187-193.
Tsantes, A. E., P. Kopterides et al. (2013). The effect of angiotensin converting enzyme gene I/D polymorphism and its expression on clinical outcome in acute respiratory distress syndrome. Minerva Anestesiol., 79: 861-870.
Wang, J. G. and J. A. (2000). Staessen Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur. J. Pharmacol., 410: 289-302.
Xueqing, Q., L. Zhigang et al. (2007). A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Euro. J. Hum. Genet., 15: 1239-1245.
Yang, K., J. Jia et al. (2014). Methylenetetrahydrofolate reductase C677T gene polymorphism and essential hypertension: a meta-analysis of 10,415 subjects. Biomed. Rep., 2: 699-708.
Zarouk, W. A., I. R. Hussein et al. (2012). Association of angiotensin converting enzyme gene (I/D) polymorphism with hypertension and type 2 diabetes. Bratisl. Lek. Listy., 113: 14-18.
